Armstrong Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Sell |
5,181
-967
| -16% | -$44.8K | 0.02% | 181 |
|
|
2025
Q1 | $348K | Hold |
6,148
| – | – | 0.03% | 138 |
|
|
2024
Q4 | $348K | Buy |
6,148
+218
| +4% | +$12.3K | 0.03% | 138 |
|
|
2024
Q3 | $307K | Sell |
5,930
-1,996
| -25% | -$103K | 0.03% | 145 |
|
|
2024
Q2 | $329K | Sell |
7,926
-338
| -4% | -$14K | 0.03% | 134 |
|
|
2024
Q1 | $424K | Hold |
8,264
| – | – | 0.04% | 112 |
|
|
2023
Q4 | $424K | Sell |
8,264
-427
| -5% | -$21.9K | 0.04% | 112 |
|
|
2023
Q3 | $504K | Buy |
8,691
+415
| +5% | +$24.1K | 0.06% | 86 |
|
|
2023
Q2 | $529K | Sell |
8,276
-36
| -0.4% | -$2.3K | 0.06% | 86 |
|
|
2023
Q1 | $576K | Buy |
8,312
+2
| +0% | +$139 | 0.07% | 79 |
|
|
2022
Q4 | $598K | Buy |
+8,310
| New | +$598K | 0.08% | 80 |
|